SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-23-096093
Filing Date
2023-12-15
Accepted
2023-12-15 16:15:29
Documents
76
Period of Report
2023-10-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q1023_enzobio.htm   iXBRL 10-Q 654565
2 CERTIFICATION f10q1023ex31-1_enzobio.htm EX-31.1 9864
3 CERTIFICATION f10q1023ex31-2_enzobio.htm EX-31.2 9723
4 CERTIFICATION f10q1023ex32-1_enzobio.htm EX-32.1 3734
5 CERTIFICATION f10q1023ex32-2_enzobio.htm EX-32.2 3780
  Complete submission text file 0001213900-23-096093.txt   4887375

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE enz-20231031.xsd EX-101.SCH 63384
7 XBRL CALCULATION FILE enz-20231031_cal.xml EX-101.CAL 48776
8 XBRL DEFINITION FILE enz-20231031_def.xml EX-101.DEF 247636
9 XBRL LABEL FILE enz-20231031_lab.xml EX-101.LAB 507594
10 XBRL PRESENTATION FILE enz-20231031_pre.xml EX-101.PRE 263641
70 EXTRACTED XBRL INSTANCE DOCUMENT f10q1023_enzobio_htm.xml XML 572940
Mailing Address ENZO BIOCHEM INC 60 EXECUTIVE BLVD FARMINGDALE NY 11735
Business Address 60 EXECUTIVE BLVD FARMINGDALE NY 11735 5167555500
ENZO BIOCHEM INC (Filer) CIK: 0000316253 (see all company filings)

IRS No.: 132866202 | State of Incorp.: NY | Fiscal Year End: 0731
Type: 10-Q | Act: 34 | File No.: 001-09974 | Film No.: 231490505
SIC: 8071 Services-Medical Laboratories